Correlation Between BioAffinity Technologies, and ECARX Holdings

Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and ECARX Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and ECARX Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between bioAffinity Technologies, and ECARX Holdings Class, you can compare the effects of market volatilities on BioAffinity Technologies, and ECARX Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of ECARX Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and ECARX Holdings.

Diversification Opportunities for BioAffinity Technologies, and ECARX Holdings

-0.08

Correlation Coefficient

BioAffinity Technologies,  ECARX Holdings

Good diversification

The 3 months correlation between BioAffinity and ECARX is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and ECARX Holdings Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ECARX Holdings Class and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with ECARX Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ECARX Holdings Class has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and ECARX Holdings go up and down completely randomly.

Pair Corralation between BioAffinity Technologies, and ECARX Holdings

Given the investment horizon of 90 days bioAffinity Technologies, is expected to generate 1.72 times more return on investment than ECARX Holdings. However, BioAffinity Technologies, is 1.72 times more volatile than ECARX Holdings Class. It trades about 0.1 of its potential returns per unit of risk. ECARX Holdings Class is currently generating about 0.02 per unit of risk. If you would invest  21.00  in bioAffinity Technologies, on May 9, 2025 and sell it today you would earn a total of  8.00  from holding bioAffinity Technologies, or generate 38.1% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

bioAffinity Technologies,  vs.  ECARX Holdings Class

bioAffinity Technologies,

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies, are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioAffinity Technologies, reported solid returns over the last few months and may actually be approaching a breakup point.

ECARX Holdings Class

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in ECARX Holdings Class are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, ECARX Holdings may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with BioAffinity Technologies, and ECARX Holdings

The main advantage of trading using opposite BioAffinity Technologies, and ECARX Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, ECARX Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ECARX Holdings will offset losses from the drop in ECARX Holdings' long position.

The idea behind bioAffinity Technologies, and ECARX Holdings Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.